Price Disclosure Guidelines
Page last updated: 8 June 2022
Information about price disclosure is detailed in the Pharmaceutical Benefits Scheme Price Disclosure Guidelines. The Guidelines are intended to provide guidance to responsible persons regarding their Price Disclosure obligations, how to comply, and the consequences of non-compliance. These Guidelines also provide details of the Price Disclosure process, such as how data is collected and processed, how the outcomes of calculations are applied to the prices of relevant pharmaceutical items and what options are available to Responsible Persons to raise disputes.
Downloadable versions of the Guidelines:
Questions in relation to the Guidelines can be sent to email@example.com.